News & Analysis of Economic, Racial, Gender Justice and More

FEATURING MERITH BASEY - The cost of prescription drugs have long been out of control in the United States, with the federal government being barred from using its buying power to negotiate down sticker prices. Now, thanks to a provision in the Inflation Reduction Act, the Centers for Medicare & Medicaid Services can begin negotiating lower drug prices. But pharmaceutical companies are already fighting back, with numerous lawsuits, placements of op-eds, and support from conservative lawmakers.

This post is for subscribers only

Subscribe now for free to watch the video of this interview (You can upgrade later to a paid membership to unlock exclusive content).

Sign up now Already have an account? Sign in
You’ve successfully subscribed to Rising Up With Sonali
Welcome back! You’ve successfully signed in.
Great! You’ve successfully signed up.
Success! Your email is updated.
Your link has expired
Success! Check your email for magic link to sign-in.